Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent

Aurélie Mbeutcha, Ilaria Lucca, Vitaly Margulis, Jose A. Karam, Christopher G. Wood, Michela de Martino, Romain Mathieu, Andrea Haitel, Evanguelos Xylinas, Luis Kluth, Morgan Rouprêt, Pierre I. Karakiewicz, Alberto Briganti, Michael Rink, Malte Rieken, Alon Z. Weizer, Jay Raman, Nathalie Rioux-Leclecq, Christian Bolenz, Karim Bensalah & 5 others Yair Lotan, Christian Seitz, Mesut Remzi, Shahrokh F. Shariat, Tobias Klatte

Research output: Contribution to journalArticle

Abstract

Background: Excision repair cross-complementing 1 (ERCC1) has been associated with outcomes of urothelial carcinoma of the bladder, but was not yet studied in upper tract urothelial carcinoma (UTUC). The aim of this study was to assess the prognostic role of ERCC1 expression in a large international cohort of UTUC patients. Methods: Immunohistochemical ERCC1 expression was evaluated in 716 UTUC patients who underwent radical nephroureterectomy with curative intent. ERCC1 was considered positive when the H-score was >1.0. Associations with overall survival and cancer-specific survival were assessed using univariable and multivariable Cox models. Results: ERCC1 was expressed in 303 tumors (42.3 %) and linked with the presence of tumor necrosis (16.2 vs. 10.4 %, p = 0.023), but not with any other clinical or pathological variable. ERCC1 status did not predict cancer-specific survival and overall survival on both univariable (p = 0.70 and 0.32, respectively) and multivariable analyses (p = 0.48 and 0.33, respectively). Conclusions: ERCC1 is expressed in a significant proportion of UTUC and is linked with tumor necrosis, but its expression appears not to be associated with prognosis following radical nephroureterectomy.

Original languageEnglish (US)
Pages (from-to)1155-1161
Number of pages7
JournalWorld Journal of Urology
Volume34
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

DNA Repair
Carcinoma
Proteins
Survival
Neoplasms
Necrosis
Proportional Hazards Models
Urinary Bladder

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Mbeutcha, Aurélie ; Lucca, Ilaria ; Margulis, Vitaly ; Karam, Jose A. ; Wood, Christopher G. ; de Martino, Michela ; Mathieu, Romain ; Haitel, Andrea ; Xylinas, Evanguelos ; Kluth, Luis ; Rouprêt, Morgan ; Karakiewicz, Pierre I. ; Briganti, Alberto ; Rink, Michael ; Rieken, Malte ; Weizer, Alon Z. ; Raman, Jay ; Rioux-Leclecq, Nathalie ; Bolenz, Christian ; Bensalah, Karim ; Lotan, Yair ; Seitz, Christian ; Remzi, Mesut ; Shariat, Shahrokh F. ; Klatte, Tobias. / Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent. In: World Journal of Urology. 2016 ; Vol. 34, No. 8. pp. 1155-1161.
@article{0582a0dc988e45e08d3ec904676ec1e3,
title = "Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent",
abstract = "Background: Excision repair cross-complementing 1 (ERCC1) has been associated with outcomes of urothelial carcinoma of the bladder, but was not yet studied in upper tract urothelial carcinoma (UTUC). The aim of this study was to assess the prognostic role of ERCC1 expression in a large international cohort of UTUC patients. Methods: Immunohistochemical ERCC1 expression was evaluated in 716 UTUC patients who underwent radical nephroureterectomy with curative intent. ERCC1 was considered positive when the H-score was >1.0. Associations with overall survival and cancer-specific survival were assessed using univariable and multivariable Cox models. Results: ERCC1 was expressed in 303 tumors (42.3 {\%}) and linked with the presence of tumor necrosis (16.2 vs. 10.4 {\%}, p = 0.023), but not with any other clinical or pathological variable. ERCC1 status did not predict cancer-specific survival and overall survival on both univariable (p = 0.70 and 0.32, respectively) and multivariable analyses (p = 0.48 and 0.33, respectively). Conclusions: ERCC1 is expressed in a significant proportion of UTUC and is linked with tumor necrosis, but its expression appears not to be associated with prognosis following radical nephroureterectomy.",
author = "Aur{\'e}lie Mbeutcha and Ilaria Lucca and Vitaly Margulis and Karam, {Jose A.} and Wood, {Christopher G.} and {de Martino}, Michela and Romain Mathieu and Andrea Haitel and Evanguelos Xylinas and Luis Kluth and Morgan Roupr{\^e}t and Karakiewicz, {Pierre I.} and Alberto Briganti and Michael Rink and Malte Rieken and Weizer, {Alon Z.} and Jay Raman and Nathalie Rioux-Leclecq and Christian Bolenz and Karim Bensalah and Yair Lotan and Christian Seitz and Mesut Remzi and Shariat, {Shahrokh F.} and Tobias Klatte",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s00345-015-1737-7",
language = "English (US)",
volume = "34",
pages = "1155--1161",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "8",

}

Mbeutcha, A, Lucca, I, Margulis, V, Karam, JA, Wood, CG, de Martino, M, Mathieu, R, Haitel, A, Xylinas, E, Kluth, L, Rouprêt, M, Karakiewicz, PI, Briganti, A, Rink, M, Rieken, M, Weizer, AZ, Raman, J, Rioux-Leclecq, N, Bolenz, C, Bensalah, K, Lotan, Y, Seitz, C, Remzi, M, Shariat, SF & Klatte, T 2016, 'Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent', World Journal of Urology, vol. 34, no. 8, pp. 1155-1161. https://doi.org/10.1007/s00345-015-1737-7

Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent. / Mbeutcha, Aurélie; Lucca, Ilaria; Margulis, Vitaly; Karam, Jose A.; Wood, Christopher G.; de Martino, Michela; Mathieu, Romain; Haitel, Andrea; Xylinas, Evanguelos; Kluth, Luis; Rouprêt, Morgan; Karakiewicz, Pierre I.; Briganti, Alberto; Rink, Michael; Rieken, Malte; Weizer, Alon Z.; Raman, Jay; Rioux-Leclecq, Nathalie; Bolenz, Christian; Bensalah, Karim; Lotan, Yair; Seitz, Christian; Remzi, Mesut; Shariat, Shahrokh F.; Klatte, Tobias.

In: World Journal of Urology, Vol. 34, No. 8, 01.08.2016, p. 1155-1161.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent

AU - Mbeutcha, Aurélie

AU - Lucca, Ilaria

AU - Margulis, Vitaly

AU - Karam, Jose A.

AU - Wood, Christopher G.

AU - de Martino, Michela

AU - Mathieu, Romain

AU - Haitel, Andrea

AU - Xylinas, Evanguelos

AU - Kluth, Luis

AU - Rouprêt, Morgan

AU - Karakiewicz, Pierre I.

AU - Briganti, Alberto

AU - Rink, Michael

AU - Rieken, Malte

AU - Weizer, Alon Z.

AU - Raman, Jay

AU - Rioux-Leclecq, Nathalie

AU - Bolenz, Christian

AU - Bensalah, Karim

AU - Lotan, Yair

AU - Seitz, Christian

AU - Remzi, Mesut

AU - Shariat, Shahrokh F.

AU - Klatte, Tobias

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Background: Excision repair cross-complementing 1 (ERCC1) has been associated with outcomes of urothelial carcinoma of the bladder, but was not yet studied in upper tract urothelial carcinoma (UTUC). The aim of this study was to assess the prognostic role of ERCC1 expression in a large international cohort of UTUC patients. Methods: Immunohistochemical ERCC1 expression was evaluated in 716 UTUC patients who underwent radical nephroureterectomy with curative intent. ERCC1 was considered positive when the H-score was >1.0. Associations with overall survival and cancer-specific survival were assessed using univariable and multivariable Cox models. Results: ERCC1 was expressed in 303 tumors (42.3 %) and linked with the presence of tumor necrosis (16.2 vs. 10.4 %, p = 0.023), but not with any other clinical or pathological variable. ERCC1 status did not predict cancer-specific survival and overall survival on both univariable (p = 0.70 and 0.32, respectively) and multivariable analyses (p = 0.48 and 0.33, respectively). Conclusions: ERCC1 is expressed in a significant proportion of UTUC and is linked with tumor necrosis, but its expression appears not to be associated with prognosis following radical nephroureterectomy.

AB - Background: Excision repair cross-complementing 1 (ERCC1) has been associated with outcomes of urothelial carcinoma of the bladder, but was not yet studied in upper tract urothelial carcinoma (UTUC). The aim of this study was to assess the prognostic role of ERCC1 expression in a large international cohort of UTUC patients. Methods: Immunohistochemical ERCC1 expression was evaluated in 716 UTUC patients who underwent radical nephroureterectomy with curative intent. ERCC1 was considered positive when the H-score was >1.0. Associations with overall survival and cancer-specific survival were assessed using univariable and multivariable Cox models. Results: ERCC1 was expressed in 303 tumors (42.3 %) and linked with the presence of tumor necrosis (16.2 vs. 10.4 %, p = 0.023), but not with any other clinical or pathological variable. ERCC1 status did not predict cancer-specific survival and overall survival on both univariable (p = 0.70 and 0.32, respectively) and multivariable analyses (p = 0.48 and 0.33, respectively). Conclusions: ERCC1 is expressed in a significant proportion of UTUC and is linked with tumor necrosis, but its expression appears not to be associated with prognosis following radical nephroureterectomy.

UR - http://www.scopus.com/inward/record.url?scp=84949638644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949638644&partnerID=8YFLogxK

U2 - 10.1007/s00345-015-1737-7

DO - 10.1007/s00345-015-1737-7

M3 - Article

VL - 34

SP - 1155

EP - 1161

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 8

ER -